ImmunityBio (IBRX) Interest & Investment Income (2015 - 2021)
ImmunityBio (IBRX) reported Interest & Investment Income of $112000.0 for Q2 2021, down 67.16% year-over-year from $341000.0 in Q2 2020, and down 98.75% on a QoQ basis from $8.9 million in Q1 2021.
ImmunityBio (IBRX) has 7 years of Interest & Investment Income data on file, last reported at $112000.0 in Q2 2021.
- Quarterly Interest & Investment Income fell 67.16% year-over-year to $112000.0 in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $9.6 million (up 724.16% YoY) and the FY2020 annual result came in at $366000.0, down 77.72% from the prior year.
- Interest & Investment Income declined to $112000.0 in Q2 2021 per IBRX's latest filing, from $8.9 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $8.9 million in Q1 2021 and bottomed at -$743000.0 in Q4 2017.
- The 5-year median for Interest & Investment Income is $440000.0 (2018), against an average of $889277.8.
- The widest annual swing landed in 2017, when Interest & Investment Income tumbled 125.92%; it then surged 11366.67% in 2021.
- Tracing IBRX's Interest & Investment Income over 5 years: stood at -$743000.0 in 2017, then jumped by 155.85% to $415000.0 in 2018, then dropped by 26.02% to $307000.0 in 2019, then slumped by 84.69% to $47000.0 in 2020, then surged by 138.3% to $112000.0 in 2021.
- Per Business Quant, the three latest IBRX Interest & Investment Income figures stand at $112000.0 (Q2 2021), $8.9 million (Q1 2021), and $47000.0 (Q4 2020).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 26.60 Mn |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 112,000.00 |
| Mar 31, 2021 | 8.94 Mn |
| Dec 31, 2020 | 47,000.00 |
| Sep 30, 2020 | 449,000.00 |
| Jun 30, 2020 | 341,000.00 |
| Mar 31, 2020 | 78,000.00 |
| Dec 31, 2019 | 307,000.00 |
| Sep 30, 2019 | 433,000.00 |
| Jun 30, 2019 | 533,000.00 |
| Mar 31, 2019 | 410,000.00 |
| Dec 31, 2018 | 415,000.00 |
| Sep 30, 2018 | 447,000.00 |
| Jun 30, 2018 | 490,000.00 |
| Mar 31, 2018 | 704,000.00 |
| Dec 31, 2017 | -743,000.00 |
| Sep 30, 2017 | 1.01 Mn |
| Jun 30, 2017 | 681,000.00 |
| Mar 31, 2017 | 1.35 Mn |
| Dec 31, 2016 | 2.87 Mn |
| Sep 30, 2016 | 1.37 Mn |
| Jun 30, 2016 | 739,000.00 |
| Mar 31, 2016 | 768,000.00 |
| Dec 31, 2015 | 2.84 Mn |
| Sep 30, 2015 | 81,000.00 |
| Jun 30, 2015 | 33,000.00 |
| Mar 31, 2015 | 32,000.00 |